Students at Purdue University, under the guidance of two professors, are developing an information database that allows for patients to undergo genetic screening and test their predisposition to a host of drugs.
If this sounds familiar, it is because certain therapeutic areas are already cashing in on this, most notably the HIV space with diagnostic phenotypic testing, but what makes this situation different is its proposed broadness-of-use.
Interestingly enough, such an application would have astounding applications during clinical trials and help bring down enormous trial related costs. Further, in the light of personalized medicine, it will enable patients to understand, beforehand, whether they will be benefit or have a negative drug interaction, with a particular agent.
Those working on the technology insist that the read-out information that will ultimately be provided to a pharmacist will not contain your predisposition to other diseases that one may have, but will only provide information relevant enough for treatment with a particular agent. Good news for the consumer!
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment